These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7969745)

  • 21. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system.
    De Lacoste MC; White CL
    Neurobiol Aging; 1993; 14(1):1-16. PubMed ID: 8450928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the subcortically lesioned rat cortex to understand the physiological role of amyloid precursor protein.
    Wallace W; Haroutunian V
    Behav Brain Res; 1993 Nov; 57(2):199-206. PubMed ID: 8117425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein--initial observations.
    Diez M; Koistinaho J; Kahn K; Games D; Hökfelt T
    Neuroscience; 2000; 100(2):259-86. PubMed ID: 11008166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease.
    Gabriel SM; Bierer LM; Davidson M; Purohit DP; Perl DP; Harotunian V
    J Neurochem; 1994 Apr; 62(4):1516-23. PubMed ID: 7510783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.
    McDonald MP; Crawley JN
    J Psychiatry Neurosci; 1997 Nov; 22(5):303-17. PubMed ID: 9401311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease.
    Passani LA; Vonsattel JP; Coyle JT
    Brain Res; 1997 Oct; 772(1-2):9-22. PubMed ID: 9406950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction.
    Schliebs R; Rossner S; Bigl V
    Prog Brain Res; 1996; 109():253-64. PubMed ID: 9009714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of Broca to dorsal hippocampus, cingulate cortex and olfactory bulb: a combined wheatgerm agglutinin-apohorseradish peroxidase-gold immunohistochemical study.
    Senut MC; Menetrey D; Lamour Y
    Neuroscience; 1989; 30(2):385-403. PubMed ID: 2473418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts.
    Zilles K; Qü M; Schleicher A; Schroeter M; Kraemer M; Witte OW
    Arzneimittelforschung; 1995 Mar; 45(3A):361-6. PubMed ID: 7763327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease.
    Davies CA; Morroll DR; Prinja D; Mann DM; Gibbs A
    J Neurol Sci; 1990 Apr; 96(1):59-73. PubMed ID: 1972185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Morrison JH
    Acta Neuropathol; 1994; 87(2):115-24. PubMed ID: 8171960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relation between hippocampal damage and cerebral cortical function in Alzheimer's disease].
    Hanyu H; Asano T; Kogure D; Sakurai H; Iwamoto T; Takasaki M
    Nihon Ronen Igakkai Zasshi; 2000 Nov; 37(11):921-7. PubMed ID: 11193370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
    Gabriel SM; Davidson M; Haroutunian V; Powchik P; Bierer LM; Purohit DP; Perl DP; Davis KL
    Biol Psychiatry; 1996 Jan; 39(2):82-91. PubMed ID: 8717605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus.
    Holets VR; Hökfelt T; Rökaeus A; Terenius L; Goldstein M
    Neuroscience; 1988 Mar; 24(3):893-906. PubMed ID: 2454419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotransmitters in the cerebral cortex.
    Jones EG
    J Neurosurg; 1986 Aug; 65(2):135-53. PubMed ID: 2873211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain gangliosides in Alzheimer's disease.
    Kracun I; Kalanj S; Cosovic C; Talan-Hranilovic J
    J Hirnforsch; 1990; 31(6):789-93. PubMed ID: 2092064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.